Faculty Member - Adjunct
Sid E. O’Bryant, Ph.D. |
||
![]() |
Positions: |
|
Education: |
Ph.D., University at Albany, State University of New York, 2004 |
|
Licenses: |
Licensed Psychologist - Texas |
|
Contact: |
Phone: (806) 743-1338, ext. 271 Fax: (806) 743-4510 Email: sid.obryant@ttuhsc.edu |
|
Awards and Honors: |
2006-2010 - Loan Repayment Program recipient National Institutes of Health (NIH)/National Center on Minority Health and Health Disparities (NCMHD) 2009 - Early Career Award, National Academy of Neuropsychology 2009 - Nelson Butter’s Award, co-recipient, National Academy of Neuropsychology 2006 - National Institute on Aging Summer Institute on Aging Research |
Research Support: |
Genetics and Biomarkers Study of Alzheimer’s Disease – The Texas Alzheimer’s Research Consortium, Texas Counsel on Alzheimer’s Disease and Related Disorders (TTUHSC Site PI and Steering Committee Member); Arsenic Exposure and Alzheimer’s Disease, South Plains Foundation (PI); Normative Data for the RBANS among English-Speaking Mexican Americans, National Academy of Neuropsychology (PI); A Community-Based Respite Care Program: A Project FRONTIER study, Carl B. & Florence E. King Foundation (Co-PI) |
Research Interests: |
My primary interest is translational/transdisciplinary research with particular emphasis on biomarker mediators of neuropsychological functioning and decline, which I conduct through 2 ongoing projects: (1) Project FRONTIER (Facing Rural Obstacles to healthcare Now Through Intervention, Education and Research), which is an epidemiological community-based participatory research (CBPR) study aimed at understanding health issues in rural multi-ethnic communities. Topics being studies include, but are not limited to, dementia and cognitive dysfunction, cardiovascular disease, obesity, diabetes, tobacco and alcohol use, environmental exposures, depression and anxiety, as well as how these health indicators vary according to gender, ethnicity, and SES. (2) The Texas Alzheimer’s Research Consortium (TARC), which is a longitudinal study of genetics and biomarkers associated with Alzheimer’s disease. My particular focus in this study is the evaluation of blood-based proteins (inflammatory and others) that have potential diagnostic, prognostic, and therapeutic utility. |
Selected Research: |
|

